▲ BUY
6
/ 10
Conviction
$ Value
$9K
Shares
2,500
Price
$4
Filed
Nov 17
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Chaudhary Zuraiz
Title
See Remarks
CIK
0002086494
Roles
Officer
Transaction Details
Transaction Date
2025-11-17
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
7,550
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.50 to $3.69, inclusive. The Reporting Person undertakes to provide to Turn Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Chaudhary Zuraiz's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | TTRX | A | $0 |
| 2025-12-12 | TTRX | ▲ | $9K |
| 2025-11-21 | TTRX | ▲ | $3K |
| 2025-11-20 | TTRX | ▲ | $4K |
| 2025-11-17 | TTRX | ▲ | $9K |
| 2025-10-23 | TTRX | ▲ | $25K ★ |
| 2025-10-08 | TTRX | A | $0 |
Other Insiders at TTRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GOLDEN ARTHUR F | — | — | 2026-04-02 |
|
Chaudhary Zuraiz
See Remarks
|
— | — | 2026-04-01 |
|
Burnam Bradley Evan
Chief Executive Officer
|
— | — | 2026-04-02 |
| Dewhurst Martin William | — | — | 2026-01-07 |